Sign In
Buy CYRX
$16.50
+0.760 (+4.83%)
At Close: Jun 03, 2026
Cryoport, Inc. (CYRX) Q1 2026 Earnings Call Transcript
01:53am, Tuesday, 05'th May 2026
Cryoport, Inc. (CYRX) Q1 2026 Earnings Call Transcript
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
06:50pm, Monday, 04'th May 2026
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.22 per share a year ago.
Cryoport Reports First Quarter 2026 Financial Results
04:05pm, Monday, 04'th May 2026
First quarter revenue grew 16% year-over-year to $47.8 million Commercial cell and gene therapy (CGT) revenue grew 26% year-over-year to $9.1 million, reflecting continued expansion in approved CGT pr
Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026
04:05pm, Monday, 20'th Apr 2026
NASHVILLE, Tenn., April 20, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for
Cryoport: Moving Toward Commercial Scalability And Near-Term Breakeven
11:46pm, Monday, 30'th Mar 2026
Cryoport receives a buy rating with a $9.1 price target, implying 17% upside by FY 2026. CYRX demonstrated double-digit revenue growth in Q4 2025, led by Life Sciences Services, and improved gross mar
CryoPort, Inc. (NASDAQ:CYRX) Receives Average Recommendation of “Moderate Buy” from Brokerages
02:23am, Monday, 23'rd Mar 2026
CryoPort, Inc. (NASDAQ: CYRX - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the ten brokerages that are presently covering the company, MarketBeat Ratings reports. O
Cryoport, Inc. (CYRX) Q4 2025 Earnings Call Transcript
11:42pm, Tuesday, 03'rd Mar 2026
Cryoport, Inc. (CYRX) Q4 2025 Earnings Call Transcript
CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates
06:25pm, Tuesday, 03'rd Mar 2026
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.42 per share a year ago.
Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results
04:05pm, Tuesday, 03'rd Mar 2026
FY 2025 revenue increased to $176.2 million, exceeding the high end of previous guidance Life Sciences Services revenue grew 18% year-over-year in FY 2025, including a 22% rise in BioStorage/BioServic
Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
08:00am, Tuesday, 17'th Feb 2026
NASHVILLE, Tenn., Feb. 17, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of temperature-controlled supply chain solutions for the life sci
Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series
08:30am, Wednesday, 11'th Feb 2026
Self-Sustaining Fusion® 800 Series Cryogenic Freezer Delivers High-Capacity Storage, Flexibility, and Cost Benefits in Limited Space Environments NASHVILLE, Tenn., Feb. 11, 2026 /PRNewswire/ -- Cry
EXCLUSIVE: New Fusion 800 Launch Signals Cryoport's Ambition To Modernize Cryogenic Storage
08:16am, Wednesday, 11'th Feb 2026
Cryoport, Inc. launched the Fusion 800 Series, a compact cryogenic storage system that eliminates the need for continuous liquid nitrogen. Revenue grew 15% in Q3, and fiscal 2025 revenue guidance was
CryoPort (NASDAQ:CYRX) vs. Royal Mail (OTCMKTS:ROYMY) Head-To-Head Contrast
02:14am, Tuesday, 13'th Jan 2026
CryoPort (NASDAQ: CYRX - Get Free Report) and Royal Mail (OTCMKTS:ROYMY - Get Free Report) are both transportation companies, but which is the better stock? We will contrast the two businesses based o
CryoPort, Inc. (NASDAQ:CYRX) Receives Consensus Recommendation of “Moderate Buy” from Analysts
03:32am, Wednesday, 07'th Jan 2026
Shares of CryoPort, Inc. (NASDAQ: CYRX - Get Free Report) have earned an average rating of "Moderate Buy" from the eleven ratings firms that are covering the stock, Marketbeat reports. One equities re
CryoPort, Inc. $CYRX Shares Bought by Assenagon Asset Management S.A.
03:25am, Saturday, 20'th Dec 2025
Assenagon Asset Management S.A. raised its stake in shares of CryoPort, Inc. (NASDAQ: CYRX) by 37.4% during the undefined quarter, according to the company in its most recent Form 13F filing with the
